07828414 · Active · incorporated 14 years, 10 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series B+
A biotherapeutics company developing treatments for autoimmune and allergic diseases by resetting the immune system.
Revolo Biotherapeutics Limited is a private limited company registered at Companies House under number 07828414, incorporated on 31 October 2011, with a registered office in Cambridge. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 158 filings for this company, including 11 funding rounds. Its most recent round closed in June 2026, raising £2.2m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 11 | Jun 2026 | £2.2m | £3.70 |
| Round 10 | Jun 2024 | £4.1m | £26.51 |
| Round 9 | Mar 2023 | £10.8m | £26.51 |
| Round 8 | Jun 2022 | £20.6m | £26.51 |
| Round 7 | Jun 2021 | £9.5m | £15.09 |
| Round 6 | Sep 2020 | £21.1m | £13.00 |
Showing the 6 most recent of 11 rounds.
Showing the 10 most recent of 158 filings.
See the complete cap table with every shareholder, founder tags, dilution across 57 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.